Mounjaro®

FDA-approved · Cash-pay · Ships to your door

Mounjaro®

FDA-approved tirzepatide pen, off-label for weight loss. Activates both appetite hormones, GIP and GLP-1.

$1,099/month

Start your visit

Nothing is charged until a clinician prescribes.

  • FDA-approved for type 2 diabetes
  • Weekly injection from a single-dose pen
  • Same price at every dose, cancel anytime
  • Cash-pay only; not billed to insurance
US-licensed pharmacyFSA & HSA eligible

The easiest way to find out is to start. Our US-licensed provider partners review a short online intake — usually just a few minutes — and determine what's right for you on an individual basis, based on your health history and goals. There's no cost to find out and no obligation.

Yes. Shipping is always free, and every order arrives in plain, unmarked packaging from a US-licensed pharmacy — no one needs to know what's inside. Most orders arrive within about a week of approval.

Yes. Pallas is a cash-pay medical service, and we provide an itemized receipt for your visit and prescription that you can submit to your FSA or HSA. Most plans treat prescription medications and telehealth visits as eligible expenses — your plan administrator can confirm what applies to you.

About

What is Mounjaro®?

Mounjaro® is the FDA-approved tirzepatide product from Eli Lilly and Company, indicated for type 2 diabetes mellitus to improve glycemic control alongside diet and exercise. It is sometimes prescribed off-label for weight management at the discretion of a licensed clinician when clinically indicated.

Pallas dispenses Mounjaro® through US-licensed pharmacies on a cash-pay basis. Insurance routing is not currently supported. Eligibility is determined by a licensed clinician based on your intake and clinical history.

Pivotal trial · SURPASS program

In the SURPASS clinical program, tirzepatide demonstrated significant HbA1c reductions across a range of T2D populations.

Source: Eli Lilly SURPASS trial program. Outcome reflects the cited trial of the FDA-approved product and the conditions studied. Individual results may differ.

Dosing

Dosing & schedule

Mounjaro® uses a dose-escalation schedule. Your clinician determines the right starting dose and pace of escalation based on your indication and tolerability.

  • Weeks 1–42.5 mg once weekly — starting dose (non-therapeutic, for tolerability)
  • Weeks 5–85 mg once weekly
  • Weeks 9+Increased every 4 weeks as tolerated, up to 15 mg weekly maintenance

Common questions

The easiest way to find out is to start. Our US-licensed provider partners review a short online intake — usually just a few minutes — and determine what's right for you on an individual basis, based on your health history and goals. There's no cost to find out and no obligation.

Yes. Shipping is always free, and every order arrives in plain, unmarked packaging from a US-licensed pharmacy — no one needs to know what's inside. Most orders arrive within about a week of approval.

Yes. Pallas is a cash-pay medical service, and we provide an itemized receipt for your visit and prescription that you can submit to your FSA or HSA. Most plans treat prescription medications and telehealth visits as eligible expenses — your plan administrator can confirm what applies to you.

We'll make it right. Pallas includes unlimited customer support — if anything's off with your shipment, or you simply have a question about your treatment, our support team and your care team are a message away, as often as you need, at no extra cost.

Pallas is cash-pay and doesn't bill insurance directly — that keeps your pricing simple and predictable. But because you receive the genuine, FDA-approved product with an itemized receipt, some patients choose to submit a claim to their insurer afterward for possible out-of-network reimbursement. Whether it's reimbursed is up to your individual plan.

Mounjaro® is the brand name for FDA-approved tirzepatide manufactured by Eli Lilly for type 2 diabetes. Tirzepatide activates both the GIP and GLP-1 receptors, delivered as a once-weekly subcutaneous injection.

Mounjaro® is FDA-approved for type 2 diabetes, and a US-licensed clinician may prescribe it off-label for weight management when it's clinically appropriate for you. If weight is your main goal, your provider can also walk you through Zepbound® — the tirzepatide product from the same manufacturer that's FDA-approved specifically for chronic weight management.

Mounjaro® is $1,099 every 4 weeks, charged only once a clinician prescribes, then renewing every 4 weeks until you cancel, with no insurance routing. Other terms are quarterly ($3,297 every 12 weeks, $1099/mo average). The price is the same at every dose, and each charge covers a supply shipped directly from a US-licensed pharmacy.

Yes — no contracts and no lock-in. You can pause or cancel your plan anytime, right from your patient portal.

Mounjaro®

$1,099/month

  • Cancel anytime
  • Free expedited shipping
  • FSA & HSA eligible
  • Care-team messaging included
Mounjaro®